Methylmercury is a ubiquitous environmental pollutant and a potent neurotoxin. Treatment of methylmercury poiso relies almost exclusively on the use of chelating agents to accelerate excretion of the metal. The present study demonstrates that oral administration of N-acetylcysteine (NAC), a widely avaiable and largely nontoxic amino acid derivative, produces a profound acceleration of urinary methylmercury excretion in mice. Mice that reeived NAC in the drinking water (10 mglml) starting at 48 hr after methylmercury amiaion excreted from 47 to 54% of the 203Hg in urine over the subsequent 48 ir, as compared to 4-10% excretion in control animals. When NAC-containig water wastgiven from the time ofmethylmercury administration, it was even more effectve at enhancing urinary methylmercury excreton and at lowering tisue mercury levels. Individuals poisoned with methylmercury exhibit severe neurological disturbances, including paresthesia, ataxia, sensory and speech impairment, and visual field constriction (1-3). These clinical symptoms become evident only after a relatively long latent period of 1-2 months. Because the damage to the central nervous system appears to be irreversible, treatment must be initiated promptly after exposure (3,5). The only way to prevent or ameliorate toxicity once methylmercury has been ingested is to accelerate its elimination from the body.Strategies for removing methylmercury indude hemodialysis, exchange transfusion, and chelation therapy, with the latter being the least invasive and most common therapeutic intervention (3,5,6). Although many chelating agents have been tested over the past four decades, no single best agent has yet been identified for use in methylmercury poisoning. Of the agents that have been examined, meso-2,3-dimercaptosuccinic acid (DMSA, succimer) and 2,3-dimercapto-1-propanesulfonic acid (DMPS, Dimaval) are the most efficient at enhancing methylmercury excretion and in preventing toxicity in both experimental animals (7-16) and humans (5,6,17 (35). We confirmed the purity ofthe synthesized CH3203HgC1 using cold vapor atomic absorption (36). The product contained less than 1% inorganic mercury impurity. NAC was purchased from Sigma Chemical Company (St. Louis, MO). It was dissolved in water, the pH adjusted to 6.7-6.8 by adding 5 M NaOH, and diluted to a final concentration of 10 mg/ml. We prepared fresh NAC solutions every 2-3 days.Female and male C57B1/6 mice (15-26 g, 8 weeks of age) were obtained from Jackson Laboratory, Bar Harbor, Maine, and from Baylor College of Medicine, Houston, Texas. The animals were maintained on Purina Mills laboratory chow with water ad libitum in a temperature-controlled room with a 12-hr alternating light cycle. Experiments were conducted in accordance with the guidelines of the National Institutes of Health for care of laboratory animals.Mice were placed individually in stainlesssteel metabolic cages (Lab Products Inc., Rochelle Park, NJ) and were allowed to acclimate to the cages for 3-4 days. Urine and feces were collected on...